Essential Thrombocythemia Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Hematopoietic Cell Transplantation
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
2022-04-01
Apr 1, 2022
C
Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
2022-02-28
Feb 28, 2022
U
Recruiting
  • CALR Gene Mutation
  • +5 more
  • Continuous Positive Airway Pressure
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
2022-03-01
Mar 1, 2022
U
Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-02-25
Feb 25, 2022
I
Recruiting
  • Essential Thrombocythemia
  • Jacksonville, Florida
  • +25 more
2022-01-31
Jan 31, 2022
U
Active, not recruiting
  • Myeloproliferative Neoplasm
  • +4 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
2022-01-20
Jan 20, 2022
U
Not yet recruiting
  • Polycythemia Vera
  • +4 more
  • Direct Oral Anticoagulants
  • Low-dose aspirin
  • Angers, France
  • +36 more
2022-01-05
Jan 5, 2022
P
Recruiting
  • Essential Thrombocythemia
  • Phoenix, Arizona
  • +60 more
2021-12-30
Dec 30, 2021
U
Suspended
  • Essential Thrombocythemia
  • +4 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • Portland, Oregon
  • +1 more
2021-12-22
Dec 22, 2021
O
Recruiting
  • Myeloproliferative Neoplasm
  • +5 more
  • Apixaban 2.5 MG Oral Tablet [ELIQUIS]
  • Aspirin 81 mg
  • Ottawa, Ontario, Canada
    The Ottawa Hospital
2021-10-28
Oct 28, 2021
T
Recruiting
  • Essential Thrombocythemia
  • Polycythemia Vera
  • Miami, Florida
    University of Miami
2021-09-23
Sep 23, 2021
S
Completed
  • Myelodysplastic Syndrome
  • +13 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2021-09-24
Sep 24, 2021
S
Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +67 more
  • Fludarabine phosphate
  • +8 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
2021-08-31
Aug 31, 2021
M
Not yet recruiting
  • Myelofibrosis
  • +2 more
  • Peptide-based vaccine
  • Poly ICLC
  • New York, New York
    Icahn School of Medicine at Mount Sinai
2021-08-24
Aug 24, 2021
Y
Completed
  • Essential Thrombocythemia
  • Anagre Cap.
  • Goyang, Gyeonggi, Korea, Republic of
  • +20 more
2021-07-20
Jul 20, 2021
F
Terminated
  • Essential Thrombocythemia
  • Tours, France
    FILO
2021-06-28
Jun 28, 2021
U
Not yet recruiting
  • Myeloproliferative Neoplasm
  • +3 more
  • CALR allele burden quantification
  • (no location specified)
2021-06-18
Jun 18, 2021
S
Completed
  • Essential Thrombocythemia
    • Paris, Cedex 13, France
    • +45 more
    2021-06-07
    Jun 7, 2021
    U
    Recruiting
    • Primary Myelofibrosis
    • +9 more
    • Observational
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    2021-04-01
    Apr 1, 2021
    M
    Recruiting
    • Acute Myeloid Leukemia
    • +15 more
    • Houston, Texas
      M D Anderson Cancer Center
    2021-03-09
    Mar 9, 2021
    S
    Active, not recruiting
    • Adult Acute Lymphoblastic Leukemia in Remission
    • +46 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    2021-02-10
    Feb 10, 2021
    F
    Completed
    • Hematopoietic/Lymphoid Cancer
    • +135 more
    • beclomethasone dipropionate
    • +4 more
    • Hackensack, New Jersey
    • +1 more
    2021-02-01
    Feb 1, 2021